Roos, Lennart https://orcid.org/0009-0007-8051-7964
Garrido-Charles, Aida https://orcid.org/0000-0002-9577-6682
Albrecht, Niels https://orcid.org/0009-0004-5243-5097
Vavakou, Anna
Alekseev, Alexey
Bleyer, Martina https://orcid.org/0009-0009-6409-0790
Thirumalai, Anupriya https://orcid.org/0000-0002-3624-0343
Mittring, Artur https://orcid.org/0000-0003-2344-5136
Alvanos, Theocharis https://orcid.org/0000-0002-0274-5642
Huet, Antoine T https://orcid.org/0000-0001-6151-7183
Bamberg, Ernst
Kusch, Kathrin https://orcid.org/0000-0002-5079-502X
Wolf, Bettina J https://orcid.org/0000-0003-0512-1381
Moser, Tobias https://orcid.org/0000-0001-7145-0533
Mager, Thomas https://orcid.org/0000-0002-9571-7033
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2067)
Deutsche Forschungsgemeinschaft (CRC1286)
Deutsche Forschungsgemeinschaft (CRC1690)
Else Kroener Fresenius Foundation (EKFZ for Optogenetic Therapies)
Ernst Jung Prize for Medicine (Ernst Jung Prize for Medicine)
Fondation Pour l'Audition (FPA RD-2020-10)
Volkswagen-Stiftung (ZN3898 and ZN4000)
EKFZ for Optogenetic Therapies (Clinician Scientist)
EXC2067 (Clinician Scientist)
Alexander von Humboldt-Stiftung
HORIZON TMA MSCA Postdoctoral Fellowship (grant 101107675)
Jacob-Henle-Programm/Else-Kroener-Fresenius-Stiftung (2021_EKPK.04)
Article History
Received: 14 March 2025
Revised: 14 November 2025
Accepted: 17 November 2025
First Online: 9 December 2025
Disclosure and competing interests statement
: TM is the co-founder of the OptoGenTech Company. The remaining authors declare no competing interests.